What is Evofem Biosciences, Inc.'s current stock price?

Evofem Biosciences, Inc. (EVFM) currently trades at USD 0.007400. Track real-time price changes and historical performance on AllInvestView.

What sector is Evofem Biosciences, Inc. in?

Evofem Biosciences, Inc. operates in the Health Care sector. AllInvestView lets you analyze sector allocation across your entire portfolio.

Evofem Biosciences, Inc. EVFM · Stock Open Evofem Biosciences, Inc. in new tab

0.007400 USD

Add to portfolio

EPS

-0.11

P/B

-0.01

Beta

-1.30

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for Evofem Biosciences, Inc. (EVFM)

Currency: USD

DCF Assumptions

Revenue growth (YoY) 0.10 Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).

EBITDA margin 0.30 Decimal (e.g., 0.30 = 30%).

Capex (% Revenue) 0.04 Decimal (e.g., 0.04 = 4%).

Tax rate 0.20 Decimal (e.g., 0.20 = 20%).

Terminal growth (g, %) 3% Percent number (e.g., 3 = 3%).

Cost of Equity (%) 10% Percent number (e.g., 10 = 10%).

Cost of Debt (%) 5% Percent number (e.g., 5 = 5%).

DCF Result

Fair Value (DCF)

—

Current Price

—

Upside

—

WACC

—

Terminal PV

—

Σ PV of FCFs

—

Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Evofem Biosciences, Inc. Analysis (EVFM)

United States Health Care Official Website Stock

Is Evofem Biosciences, Inc. a good investment? Evofem Biosciences, Inc. (EVFM) is currently trading at 0.007400 USD.

Earnings Schedule: Evofem Biosciences, Inc. is expected to release its next earnings report on Nov. 12, 2026. The market consensus estimate for Forward EPS is -0.55.

Investor FAQ

Does Evofem Biosciences, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Evofem Biosciences, Inc.?

Evofem Biosciences, Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Nov. 12, 2026. The company currently has a trailing EPS of -0.11.

Company Profile

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a hormone-free contraceptive vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Exchange Ticker

NMS (United States) EVFM

FRA (Germany) 1AQ1.F

STU (Germany) 1AQ1.SG

Trades

Dividend History paid per year (USD)

No dividend history available.

Stock Splits

Split Date	Split Ratio to 1
Jan. 18, 2018	0.17
May 6, 2022	0.07
May 18, 2023	1:100

Evofem Biosciences, Inc. EVFM · Stock Open Evofem Biosciences, Inc. in new tab

Key Metrics

Growth

Estimates

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Evofem Biosciences, Inc. Analysis (EVFM)

Investor FAQ

Company Profile

Fundamentals

Under Construction

Evofem Biosciences, Inc. EVFM · Stock Open Evofem Biosciences, Inc. in new tab

Key Metrics

Growth

Estimates

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Evofem Biosciences, Inc. Analysis (EVFM)

Investor FAQ

Company Profile

Explore Premium Features

Fundamentals

Under Construction

Community Discussion

Notifications